Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03577587Not ApplicableCompleted

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Role: lead

NCT05150288Not ApplicableCompleted

Human Milk Oligosaccharides (HMOs) Post-market Study on Infants (NEHMO)

Role: collaborator

NCT04736082Not ApplicableCompleted

Safety of an Infant Formula With Hydrolysed Protein in Term Infants

Role: collaborator

NCT02469402Not ApplicableCompleted

Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality

Role: lead

NCT01603719Not ApplicableCompleted

Efficacy and Safety of an Infant Formula With Milkfat and Prebiotics

Role: lead

All 5 trials loaded